CERO THERAPEUTICS HOLDINGS, INC. Increase (Decrease) in Other Operating Assets and Liabilities, Net
CERO THERAPEUTICS HOLDINGS, INC. (CERO) reported Increase (Decrease) in Other Operating Assets and Liabilities, Net of $929.35 million for the 2-month period ending 2024-03-31, per its 10-Q filed 2024-05-17.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet · last filed 2024-05-17
- 2024-03-31: Increase (Decrease) in Other Operating Assets and Liabilities, Net 2 month $929.35M.
| Period end | Increase (Decrease) in Other Operating Assets and Liabilities, Net 2 month |
|---|---|
| 2024-03-31 | $929.35M 10-Q · filed 2024-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |